We are launching a crowdfunding initiative to fuel the next critical step in our journey: Phase 1 clinical trials for our groundbreaking B cell-mediated vaccine platform. This trial represents a pivotal moment in demonstrating the safety and efficacy of our innovative technology.

Your support will directly contribute to advancing this first-in-class therapeutic approach, helping us validate its ability to overcome the limitations of traditional cancer vaccines. By joining our crowdfunding effort, you become part of a movement to revolutionize oncology and bring life-changing therapies closer to reality.

Together, we can unlock the paradigm-shifting potential of vaccines in cancer treatment and pave the way for a new era in immunotherapy.